New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
13:10 EDTMDASMedAssets reiterates guidance for FY12 adjusted EPS $1.10 at midpoint
Consensus $1.12. Reiterates view of FY12 revenue $635.0M at midpoint, consensus $636.2M. Says consolidated net revenue guidance increased by about 1.5% following its Q3 report based on nine]month 2012 performance and visibility through remainder of year. Says YTD 2012 results ahead of its expectations. Guidance and comments from presentation slides for J.P. Morgan Healthcare Conference.
News For MDAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
10:02 EDTMDASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:18 EDTMDASMedAssets downgraded to Sector Weight from Overweight at KeyBanc
Keybanc downgraded MedAssets to Sector Weight based on healthy valuation and concerns that EBITDA growth may be limited due to negative mix shift in 2016.
July 29, 2015
16:29 EDTMDASMedAssets sees FY15 EPS $1.20-$1.26, consensus $1.19
Sees FY15 revenue $756M-$768M, consensus $759.58M. The company raised the midpoints of its full-year 2015 consolidated financial guidance, realigned the segment revenue mix based on year-to-date results, and narrowed the guidance ranges.
16:27 EDTMDASMedAssets reports Q2 EPS 31c, consensus 27c
Subscribe for More Information
July 21, 2015
10:01 EDTMDASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:04 EDTMDASMedAssets downgraded to Market Perform from Outperform at Cowen
Cowen downgraded MedAssets to Market Perform and lowered its price target to $22 from $25. The firm believes shares reflect optimism around a transformative corporate event such as a split between the SCM and RCM segments, that is less likely to happen.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use